HCV carriers with persistently normal aminotransferase levels:: normal does not always mean healthy

被引:39
作者
Puoti, C [1 ]
机构
[1] E De Santis Hosp, Dept Gastroenterol & Internal Med, I-00045 Rome, Italy
关键词
D O I
10.1016/S0168-8278(03)00018-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:529 / 532
页数:4
相关论文
共 35 条
  • [1] HEPATITIS-C VIREMIA AND LIVER-DISEASE IN SYMPTOM-FREE INDIVIDUALS WITH ANTI-HCV
    ALBERTI, A
    MORSICA, G
    CHEMELLO, L
    CAVALLETTO, D
    NOVENTA, F
    PONTISSO, P
    RUOL, A
    [J]. LANCET, 1992, 340 (8821) : 697 - 698
  • [2] Treatment of patients with hepatitis C and normal serum aminotransferase levels
    Bacon, BR
    [J]. HEPATOLOGY, 2002, 36 (05) : S179 - S184
  • [3] Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease
    Brambilla, S
    Bellati, G
    Asti, M
    Lisa, A
    Candusso, ME
    D'Amico, M
    Grassi, G
    Giacca, M
    Franchini, A
    Bruno, S
    Ideo, G
    Mondelli, MU
    Silini, EM
    [J]. HEPATOLOGY, 1998, 27 (06) : 1678 - 1686
  • [4] Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign?
    Cividini, A
    Rebucci, C
    Silini, E
    Mondelli, MU
    [J]. GASTROENTEROLOGY, 2001, 121 (06) : 1526 - 1527
  • [5] Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity
    Curran, R
    Jameson, CL
    Craggs, JK
    Grabowska, AM
    Thomson, BJ
    Robins, A
    Irving, WL
    Ball, JK
    [J]. JOURNAL OF GENERAL VIROLOGY, 2002, 83 : 11 - 23
  • [6] Combination of interferon and ribavirin in chronic hepatitis C: Re-treatment of nonresponders to interferon
    Di Bisceglie, AM
    Thompson, J
    Smith-Wilkaitis, N
    Brunt, EM
    Bacon, BR
    [J]. HEPATOLOGY, 2001, 33 (03) : 704 - 707
  • [7] The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C
    Gordon, SC
    Fang, JWS
    Silverman, AL
    McHutchison, JG
    Albrecht, JK
    [J]. HEPATOLOGY, 2000, 32 (02) : 400 - 404
  • [8] Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection
    Hayashi, J
    Kishihara, Y
    Yamaji, K
    Furusyo, N
    Yamamoto, T
    Pae, Y
    Etoh, Y
    Ikematsu, H
    Kashiwagi, S
    [J]. HEPATOLOGY, 1997, 25 (03) : 697 - 701
  • [9] A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia
    Hayashi, J
    Furusyo, N
    Ariyama, I
    Sawayama, Y
    Etoh, Y
    Kashiwagi, S
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05) : 1523 - 1527
  • [10] A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase
    Hui, CK
    Belaye, T
    Montegrande, K
    Wright, TL
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 (04) : 511 - 517